Tokio Marine Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-18,800
Closed -$164K 567
2024
Q1
$164K Buy
18,800
+6,000
+47% +$72.8K 0.01% 559
2023
Q4
$146K Hold
12,800
0.01% 553
2023
Q3
$123K Sell
12,800
-100
-0.8% -$980 0.01% 559
2023
Q2
$137K Buy
12,900
+1,300
+11% +$14K 0.01% 564
2023
Q1
$122K Buy
11,600
+1,400
+14% +$15.7K 0.01% 560
2022
Q4
$126K Sell
10,200
-4,200
-29% -$47.6K 0.01% 533
2022
Q3
$149K Sell
14,400
-6,100
-30% -$69.2K 0.01% 497
2022
Q2
$236K Buy
20,500
+2,700
+15% +$31.8K 0.02% 438
2022
Q1
$224K Sell
17,800
-4,300
-19% -$49.3K 0.02% 460
2021
Q4
$258K Buy
22,100
+3,600
+19% +$44.2K 0.02% 427
2021
Q3
$242K Sell
18,500
-1,700
-8% -$22K 0.02% 401
2021
Q2
$260K Buy
20,200
+600
+3% +$6.87K 0.02% 353
2021
Q1
$219K Sell
19,600
-10,000
-34% -$106K 0.02% 353
2020
Q4
$337K Buy
29,600
+3,300
+13% +$36.1K 0.04% 238
2020
Q3
$237K Buy
26,300
+6,000
+30% +$59.6K 0.03% 250
2020
Q2
$209K Sell
20,300
-9,000
-31% -$92.1K 0.03% 242
2020
Q1
$296K Buy
+29,300
New +$344K 0.05% 159

Other funds holding IRWD

Tokio Marine Asset Management's IRWD Position: Q2 2024 in Review

Tokio Marine Asset Management sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2024, closing a stake of 18,800 shares — an estimated $164K sold.

Tokio Marine Asset Management first reported a position in IRWD in Q1 2020 and held it in 17 quarters. The position peaked at $337K in Q4 2020. 226 funds tracked by Wall St. Rank hold IRWD as of Q2 2024.

  • Tokio Marine Asset Management reported no remaining Ironwood Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Tokio Marine Asset Management sold 18,800 Ironwood Pharmaceuticals shares in Q2 2024, an estimated $164K.
  • Tokio Marine Asset Management first reported a position in Ironwood Pharmaceuticals in Q1 2020 and held it in 17 quarters.
  • Tokio Marine Asset Management's Ironwood Pharmaceuticals position peaked at $337K in Q4 2020.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2024.

Based on Tokio Marine Asset Management's 13F filing for Q2 2024, filed 26 Jul 2024.